Connable Office Inc. Increases Stock Holdings in Cabot Corporation $CBT

Connable Office Inc. lifted its position in Cabot Corporation (NYSE:CBT) by 13.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,134 shares of the specialty chemicals company’s stock after purchasing an additional 1,118 shares during the quarter. Connable Office Inc.’s holdings in Cabot were worth $685,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the company. American Century Companies Inc. boosted its stake in Cabot by 13.2% during the first quarter. American Century Companies Inc. now owns 1,498,268 shares of the specialty chemicals company’s stock worth $124,566,000 after buying an additional 174,921 shares during the period. Dimensional Fund Advisors LP boosted its stake in Cabot by 8.2% during the first quarter. Dimensional Fund Advisors LP now owns 1,426,693 shares of the specialty chemicals company’s stock worth $118,606,000 after buying an additional 108,397 shares during the period. Fuller & Thaler Asset Management Inc. boosted its stake in Cabot by 1.7% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,190,886 shares of the specialty chemicals company’s stock worth $99,010,000 after buying an additional 19,333 shares during the period. LSV Asset Management boosted its stake in Cabot by 318.0% during the first quarter. LSV Asset Management now owns 571,034 shares of the specialty chemicals company’s stock worth $47,476,000 after buying an additional 434,434 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its stake in Cabot by 1.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 467,532 shares of the specialty chemicals company’s stock worth $38,872,000 after buying an additional 4,619 shares during the period. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Insider Activity

In other news, CEO Sean D. Keohane sold 114,436 shares of the firm’s stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the transaction, the chief executive officer directly owned 361,518 shares in the company, valued at approximately $28,661,147.04. This trade represents a 24.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 3.03% of the company’s stock.

Cabot Stock Performance

Shares of CBT opened at $65.87 on Tuesday. The company has a current ratio of 2.13, a quick ratio of 1.41 and a debt-to-equity ratio of 0.66. The firm has a market cap of $3.50 billion, a PE ratio of 8.61 and a beta of 0.88. The company’s 50 day simple moving average is $75.13 and its 200-day simple moving average is $76.00. Cabot Corporation has a 12-month low of $65.40 and a 12-month high of $117.46.

Cabot (NYSE:CBT) last announced its earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.74 by ($0.04). Cabot had a return on equity of 25.68% and a net margin of 11.14%.Cabot’s revenue for the quarter was down 10.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.80 EPS. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. As a group, equities analysts predict that Cabot Corporation will post 7.57 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CBT. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research note on Wednesday, October 8th. UBS Group set a $82.00 price target on shares of Cabot and gave the stock a “neutral” rating in a research report on Tuesday, August 5th. Finally, Mizuho dropped their price objective on shares of Cabot from $90.00 to $88.00 and set an “outperform” rating on the stock in a research report on Friday, October 3rd. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $85.00.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.